Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective: To investigate the potential protective effects of amitriptyline and fluoxetine in a catecholamine cell model. Methods: Cultured rat pheochromocytoma (PC12) cells were pretreated with amitriptyline or fluoxetine for 24 or 48 hours and were then subjected to neurotoxic insult (200 μmol/L hydrogen peroxide). Cell viability was determined by measurement of the reduction product of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT). The enzyme activity of superoxide dismutase (SOD) was determined by a commercial SOD assay kit. Results: The decrease in cell viability induced by hydrogen peroxide was attenuated in PC12 cells pretreated with 100 μmol/L amitriptyline for 24 hours or with 50 μmol/L amitriptyline or 50 μmol/L fluoxetine for 48 hours. Pretreatment with either amitriptyline or fluoxetine was associated with increased SOD activity in PC12 cells. Inhibition of SOD activity with diethyldithiocarbamic acid reduced the cytoprotective action of fluoxetine. Conclusions: These data suggest that the neuroprotective actions of some antidepressants include the upregulation of SOD activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Hippocampal damage associated with prolonged glucocorticoid exposure in primates
Sapolsky, R., Uno, H., Rebert, C., & Finch, C. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-09-02897.1990 · Cited by 1,103
Woolley, C. S., Gould, E., & McEwen, B. S. (1990) · Brain Research · doi:10.1016/0006-8993(90)90778-a · Cited by 1,020
Magariños, A. M., McEwen, B. S., Flügge, G., & Fuchs, E. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03534.1996 · Cited by 864
PSYCHONEUROENDOCRINOLOGY OF DEPRESSION
Plotsky, P. M., Owens, M. J., & Nemeroff, C. B. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70006-x · Cited by 672
Cited by
Gałecki, P., Szemraj, J., Bieńkiewicz, M., Florkowski, A., & Gałecka, E. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70084-2 · Cited by 214
Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205
“Also, pretreatment with amitriptyline and fluoxetine was associated with increased SOD activity, and no signs of cell death were observed in the treated cells [10].”
BackgroundIn vivo antioxidant status: A putative target of antidepressant action
Zafir, A., Ara, A., & Banu, N. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.010 · Cited by 183
“Some antidepressant drugs have been demonstrated to up-regulate gene expression and activity of the important neuroprotective antioxidant enzyme superoxide dismutase (SOD) (Li et al., 2000; Kolla et al., 2005).”
BackgroundThe role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment
Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.546801 · Cited by 140
“Nortriptyline inhibited neuronal cell death, protecting isolated mitochondria against programmed cell death, inhibiting the release of apoptotic mitochondrial factors and caspases (276).”
BackgroundGałecki, P., Szemraj, J., Bieńkiewicz, M., Zboralski, K., & Gałecka, E. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1014 · Cited by 124
Posser, T., Kaster, M. P., Baraúna, S. C., Rocha, J. B. T., Rodrigues, A. L. S., & Leal, R. B. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.055 · Cited by 86
Antidepressant Action on Mitochondrial Dysfunction in Psychiatric Disorders
Adzic, M., Brkic, Z., Bulajic, S., Mitic, M., & Radojcic, M. B. (2016) · Drug Development Research · doi:10.1002/ddr.21332 · Cited by 60
Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells
Schmidt, A. J., Heiser, P., Hemmeter, U. M., Krieg, J.-C., & Vedder, H. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.024 · Cited by 40
“Effects of antidepressants on activities of antioxidant enzymes are described in cell cultures (Ji et al., 2004; Kolla et al., 2005), animal models (Xu et al., 2003) and patients with psychiatric diseases like major depression (Bilici et al., 2001; Herken et al., 2007; Khanzode et al., 2003;…”
Choe, Y. M., Kim, K. W., Jhoo, J. H., Ryu, S. H., Seo, E. H., Sohn, B. K., Byun, M. S., Bak, J., Lee, J., Yun, H. J., et al. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4384 · Cited by 31
“…that SSRIs including fluoxetine, citalopram, sertraline, paroxetine, and escitalopram not only stimulate hippocampal neurogenesis (Malberg et al., 2000; Santarelli et al., 2003; Kim et al., 2013) but also protect neurons against various neurotoxic insults (Haynes et al., 2004; Kolla et al., 2005).”
BackgroundInfluential
Metadata
- Authors
- Kolla, N., Wei, Z., Richardson, J. S., & Li, X.-M.
- Venue
- Journal of Psychiatry and Neuroscience
- Publisher
- Canadian Science Publishing
- Published
- 2005-05
- Volume
- 30
- Issue
- 3
- Pages
- 196-201
- ISSN
- 1180-4882 (ISSN-L)
- 1488-2434
- OpenAlex
- W1884392588
- Cited by
- 113
- References
- 9
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.